SUNRIDGE MEDICAL • SCOTTSDALE, ARIZONA
Alternative Prostate Cancer Treatment & Integrative Prostate Cancer Care
People searching for alternative prostate cancer treatment are often looking for a broader, physician-directed strategy that considers the cancer, the hormone environment, immune function, inflammation, metabolism, prior treatment response and the patient’s overall ability to tolerate therapy.
At Sunridge Medical in Scottsdale, Arizona, our integrative oncology programs for prostate cancer are individualized around the patient’s stage, PSA pattern, Gleason score or Grade Group, imaging, biopsy findings, molecular testing, prior treatment and current medical condition.
A physician-directed program may incorporate intravenous therapies, high-dose IV vitamin C, hyperthermia, botanical medicine, mistletoe, oxidative therapies, metabolic strategies, nutritional medicine and other individualized approaches selected according to the clinical situation.
The objective is to create a more comprehensive strategy for patients seeking natural and alternative prostate cancer treatment.
UNDERSTANDING THE DIAGNOSIS
Prostate Cancer Is Not One Disease
Prostate cancer can range from slow-growing localized disease to aggressive, metastatic or castration-resistant cancer.
Modern treatment decisions may depend on PSA level, PSA velocity, biopsy findings, Gleason score or Grade Group, MRI results, PSMA PET imaging, lymph-node involvement, bone metastases, prior treatment and molecular findings.
The National Cancer Institute lists active surveillance, surgery, radiation therapy, radiopharmaceutical therapy, hormone therapy, chemotherapy, targeted therapy and immunotherapy among prostate cancer treatment categories.1
For this reason, an alternative prostate cancer treatment program should begin with a careful review of the cancer rather than a generic protocol.
PERSONALIZED REVIEW
A More Individualized Approach to Prostate Cancer
At Sunridge Medical, treatment planning begins by reviewing the clinical picture in detail.
Depending upon the patient, our physicians may review:
- PSA history and PSA doubling time
- Biopsy results, Gleason score and Grade Group
- MRI and PSMA PET findings
- Lymph-node or bone involvement
- Prior surgery, radiation, hormone therapy, chemotherapy or targeted therapy
- Current testosterone suppression or androgen receptor therapy
- Bone health and risk of skeletal complications
- Kidney, liver and blood-count status
- Inflammatory and metabolic markers
- Current medications and treatment interactions
- Overall physical condition and treatment tolerance
This information helps determine which physician-directed integrative therapies may reasonably fit within the broader prostate cancer treatment plan.
LOCALIZED • RECURRENT • METASTATIC
Localized, Recurrent and Stage IV Prostate Cancer Require Different Strategies
A man with low-risk localized prostate cancer has a very different situation from a patient with rising PSA after surgery, bone metastases, lymph-node disease or castration-resistant prostate cancer.
Some patients are considering active surveillance. Others are weighing surgery, radiation, brachytherapy, androgen deprivation therapy, chemotherapy, PSMA-directed radioligand therapy or targeted therapy.
An integrative prostate cancer treatment plan must be adapted to the stage and biology of the disease. The program for a newly diagnosed patient is not the same as the program for recurrent or metastatic prostate cancer.
HORMONE BIOLOGY
Androgen Signaling and Prostate Cancer
Prostate cancer is often strongly influenced by androgen signaling. This is why hormone therapy, also called androgen deprivation therapy, is commonly used in advanced or recurrent disease.
Many men receiving conventional prostate cancer treatment may be taking medications that suppress testosterone production or block androgen receptor signaling.
In an integrative program, this hormone environment matters. Fatigue, hot flashes, body-composition changes, anemia, bone loss, metabolic changes and quality-of-life issues may all be relevant when developing supportive care around ADT or androgen receptor pathway inhibitors.
At Sunridge Medical, natural and intravenous therapies are selected with attention to the patient’s cancer biology, hormone therapy, lab findings and overall medical condition.
PRECISION ONCOLOGY
Molecular and Genetic Testing Can Change the Strategy
In advanced prostate cancer, molecular and genetic testing can identify treatment-relevant abnormalities.
Testing may include DNA repair genes such as BRCA1, BRCA2, ATM, PALB2, CHEK2 and mismatch-repair genes, depending upon the clinical scenario. NCI’s genetics summary notes that prostate cancer guidelines include multiple DNA repair and mismatch-repair genes in germline testing considerations.2
These findings can influence eligibility for targeted treatments, immunotherapy or clinical trials.
For patients pursuing natural prostate cancer treatment, molecular information remains important because an integrative plan should be built with the best available understanding of the tumor’s biology.
MODERN PROSTATE CANCER OPTIONS
PSMA, PARP Inhibitors and Targeted Treatment Context
Prostate cancer treatment has changed significantly with the emergence of PSMA-directed imaging and radioligand therapy, as well as targeted therapies for selected molecular groups.
The FDA expanded the indication for lutetium Lu 177 vipivotide tetraxetan for PSMA-positive metastatic castration-resistant prostate cancer in 2025.3
The FDA has also approved olaparib with abiraterone and prednisone or prednisolone for selected BRCA-mutated metastatic castration-resistant prostate cancer patients.4
These developments are important because patients seeking integrative care still benefit from knowing whether precision-treatment opportunities exist.
PHYSICIAN-DIRECTED IV THERAPY
Intravenous Therapies in Integrative Prostate Cancer Care
Intravenous therapies are commonly used in integrative oncology because selected nutrients and compounds can enter the circulation directly and, in some cases, achieve blood concentrations that are not possible through oral administration.
At Sunridge Medical, IV treatment is individualized according to the patient’s prostate cancer status, PSA pattern, prior treatment, kidney function, liver function, blood counts, medications and current oncology plan.
Depending upon the case, IV therapy may be incorporated into a broader strategy addressing oxidative balance, cellular metabolism, nutritional status, treatment recovery and overall physiologic resilience.
RESEARCH-BASED INTEGRATIVE THERAPY
High-Dose Intravenous Vitamin C
High-dose intravenous vitamin C is one of the most widely discussed physician-directed natural therapies in integrative oncology. Intravenous administration produces blood concentrations that cannot ordinarily be achieved orally.
The National Cancer Institute maintains a dedicated evidence review of IV vitamin C in cancer care. NCI notes that two studies reported improved quality of life and decreased cancer-related toxicities, while a single-arm pilot study in castration-resistant prostate cancer did not observe PSA reduction or tumor regression.5
A randomized, placebo-controlled, double-blind trial evaluating high-dose IV vitamin C with docetaxel in progressive metastatic castration-resistant prostate cancer was published in 2024.6
At Sunridge Medical, IV vitamin C may be considered within an individualized alternative prostate cancer treatment program when clinically appropriate after reviewing kidney function, medications, lab findings and current treatment.
ADVANCED INTEGRATIVE STRATEGIES
Hyperthermia and Prostate Cancer
Hyperthermia uses controlled heat as part of a physician-directed cancer-treatment strategy. Heating tumor tissue can influence blood flow, cellular stress responses and sensitivity to radiation or other therapies.
Hyperthermia has been studied in prostate cancer. A long-term report from Dana-Farber evaluating hyperthermia with radiation for locally advanced prostate cancer described promising outcomes and feasibility in a prospective phase II setting.7
Other clinical publications have evaluated local or regional hyperthermia approaches in prostate cancer.8
At Sunridge Medical, hyperthermia may be considered as one component of a broader integrative program when appropriate for the patient’s disease location, prior radiation history, metastatic pattern and overall medical condition.
BOTANICAL & NATURAL MEDICINE
Botanical Medicine and Natural Compounds
Botanical medicine is an important part of naturopathic oncology. Plant-derived compounds can influence inflammatory signaling, oxidative stress, immune activity, androgen-related pathways, cellular signaling and metabolism.
Depending upon the patient, physician-directed natural medicine may consider concentrated compounds derived from curcumin, green tea, medicinal mushrooms, mistletoe, resveratrol-related compounds and other botanical sources.
The goal is not to give every prostate cancer patient the same supplement list. Botanical and natural therapies should be selected around the patient’s diagnosis, medications, hormone therapy, laboratory findings and treatment goals.
MISTLETOE THERAPY
Mistletoe in Integrative Prostate Cancer Care
Mistletoe extracts have been used in European integrative oncology for decades and continue to be investigated in cancer care.
The National Cancer Institute maintains an evidence review of mistletoe extracts and notes that the therapy has been investigated in clinical studies, while also stating that stronger trials are needed to define its role.9
Recent laboratory research has also examined mistletoe extracts in prostate cancer cell models.10
At Sunridge Medical, mistletoe may be considered as one part of a physician-directed natural prostate cancer treatment strategy. It is not treated as a universal protocol.
METABOLIC & BONE HEALTH
Metabolic Changes, Bone Health and Treatment Tolerance
Advanced prostate cancer and androgen deprivation therapy can affect bone, muscle, blood sugar regulation, cardiovascular risk, red blood cell production and overall treatment tolerance.
For men with bone metastases, skeletal health becomes especially important. NCI notes that treatments may be used for bone pain caused by bone metastases or hormone therapy.1
An integrative prostate cancer program may therefore review vitamin D status, inflammatory markers, blood counts, metabolic markers, kidney function and other factors that influence therapy selection and recovery.
COORDINATED INTEGRATIVE CARE
Integrative Support During ADT, Radiation, Chemotherapy or Targeted Therapy
Many patients receiving care at Sunridge Medical continue treatment with their urologist, radiation oncologist or medical oncologist.
Integrative care can be coordinated around androgen deprivation therapy, radiation, surgery, chemotherapy, PSMA-directed radioligand therapy, targeted therapy or immunotherapy.
Laboratory monitoring, treatment timing, kidney and liver function, blood counts, cardiovascular health, bone health and medication interactions all influence which natural, IV or metabolic therapies are appropriate.
The purpose is to build a coordinated strategy rather than layer treatments together without considering the patient’s current oncology plan.
ADVANCED & METASTATIC DISEASE
Alternative Treatment for Stage IV Prostate Cancer
A significant number of men seeking integrative cancer care have recurrent, metastatic or Stage IV prostate cancer.
Metastatic prostate cancer may involve lymph nodes, bone, lung, liver or other organs. Some patients still respond to hormone-based treatment, while others develop castration-resistant disease.
An individualized Stage IV program may incorporate physician-directed IV therapies, high-dose IV vitamin C, hyperthermia, botanical medicine, mistletoe, oxidative therapies, metabolic strategies and other integrative approaches selected according to disease burden, PSA pattern, imaging, organ function and prior treatment response.
WHEN PREVIOUS TREATMENT HAS STOPPED WORKING
Re-Evaluating Prostate Cancer After Progression
Progression after surgery, radiation, hormone therapy, chemotherapy or targeted therapy does not necessarily mean that every option has been evaluated.
A reassessment may include:
- Reviewing biopsy and pathology
- Reviewing PSA kinetics
- Reassessing MRI, CT, bone scan or PSMA PET findings
- Evaluating whether molecular testing has been completed
- Considering germline and somatic DNA repair testing
- Evaluating PSMA-directed treatment eligibility
- Reviewing clinical-trial opportunities
- Determining which integrative therapies remain appropriate
A changing cancer may require a changing treatment strategy.
THE SUNRIDGE APPROACH
Why Patients Choose Sunridge Medical
Sunridge Medical focuses on integrative and naturopathic approaches to complex cancer cases.
Depending upon the individual patient, a program may incorporate:
- Integrative and naturopathic oncology
- High-dose IV vitamin C
- Other physician-directed intravenous therapies
- Hyperthermia
- Botanical medicine
- Mistletoe therapy
- Oxidative therapies
- Metabolic medicine
- Nutritional medicine
- Laboratory monitoring
- Review of PSA, imaging and molecular testing
- Personalized cancer-treatment planning
The exact combination varies from patient to patient. Personalization is central to the treatment strategy.
SCOTTSDALE • PHOENIX • ARIZONA
Alternative Prostate Cancer Treatment in Scottsdale, Arizona
Sunridge Medical is located in Scottsdale, Arizona, serving patients from Scottsdale, Phoenix and communities throughout Arizona.
We also work with patients who travel from across the United States and internationally for integrative cancer care.
People searching for alternative prostate cancer treatment, natural prostate cancer treatment, integrative prostate cancer treatment, Stage IV prostate cancer treatment or an integrative cancer center in Scottsdale may be looking for a physician-directed approach that considers more than one treatment modality.
FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions About Alternative Prostate Cancer Treatment
What is alternative prostate cancer treatment?
At Sunridge Medical, alternative and integrative prostate cancer care may include physician-directed IV therapies, high-dose IV vitamin C, hyperthermia, botanical medicine, mistletoe, metabolic strategies, oxidative therapies and other individualized treatments selected according to the patient’s clinical situation.
What is integrative prostate cancer treatment?
Integrative prostate cancer treatment combines physician-directed natural and supportive therapies with a detailed understanding of the patient’s PSA history, biopsy findings, imaging, molecular testing, previous treatments and current oncology plan.
Does Sunridge Medical work with Stage IV prostate cancer?
Patients with advanced and metastatic cancers seek care at Sunridge Medical. Treatment selection depends upon PSA pattern, imaging, metastatic sites, prior therapies, hormone sensitivity, molecular findings and organ function.
Is molecular testing important in prostate cancer?
Yes. In advanced disease, molecular and genetic testing may identify DNA repair or mismatch-repair abnormalities that can influence targeted therapy, immunotherapy or clinical-trial options.
Does Sunridge Medical offer IV vitamin C?
High-dose IV vitamin C is among the physician-directed therapies that may be considered within an individualized integrative cancer program. NCI maintains an evidence review of IV vitamin C, including prostate-cancer-specific clinical data.
Has hyperthermia been studied in prostate cancer?
Yes. Published clinical studies have evaluated hyperthermia in prostate cancer, including combinations with radiation therapy.
Can integrative therapies be used during hormone therapy or radiation?
They may be considered, but selection and timing should be individualized around the patient’s medications, radiation schedule, blood counts, kidney function, liver function, cardiovascular status and bone health.
Where is Sunridge Medical located?
Sunridge Medical is located in Scottsdale, Arizona, within the Phoenix metropolitan area, and works with local, national and international cancer patients.
BECOME A PATIENT
Explore a More Comprehensive Approach to Prostate Cancer
Prostate cancer treatment can involve complex decisions involving PSA, Gleason score, MRI, PSMA PET imaging, androgen signaling, molecular testing, radiation, hormone therapy and integrative care.
At Sunridge Medical, those clinical details are brought together with physician-directed natural and integrative therapies to create an individualized strategy.
Call our Patient Care Team to discuss your diagnosis, previous treatment and current goals.
SOURCES
References
- National Cancer Institute. Prostate Cancer Treatment (PDQ®) – Health Professional Version.
- National Cancer Institute / NCBI Bookshelf. Genetics of Prostate Cancer (PDQ®).
- U.S. Food and Drug Administration. FDA expands Pluvicto’s metastatic castration-resistant prostate cancer indication.
- U.S. Food and Drug Administration. FDA approves olaparib with abiraterone and prednisone or prednisolone for BRCA-mutated metastatic castration-resistant prostate cancer.
- National Cancer Institute. Intravenous Vitamin C (PDQ®) – Health Professional Version.
- Paller CJ, et al. High-dose intravenous vitamin C combined with docetaxel in metastatic castration-resistant prostate cancer. 2024. PMID: 39076107.
- Hurwitz MD, et al. Hyperthermia combined with radiation for locally advanced prostate cancer: long-term results. PMID: 20886629.
- Maluta S, et al. Conformal radiotherapy plus local hyperthermia in prostate cancer. PMID: 17701536.
- National Cancer Institute. Mistletoe Extracts (PDQ®) – Health Professional Version.
- Markowitsch SD, et al. Mistletoe extracts inhibit progressive growth of prostate cancer cells. 2025. PMID: 41090763.
